| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
The views expressed by authors of contributions in the American Journal of Health-System Pharmacy do not necessarily reflect the policy of ASHP or the institution with which the author is affiliated, unless this is clearly specified. Policy statements and official positions of ASHP are clearly labeled as such. Authors, reviewers, editorial board members, contributing editors, and AJHP editors are required to declare potential conflicts of interest regarding manuscripts submitted for publication.
Articles in the American Journal of Health-System Pharmacy are abstracted and indexed in International Pharmaceutical Abstracts. Other secondary sources that cover the American Journal of Health-System Pharmacy articles are Biological Abstracts; Chemical Abstracts; Cumulative Index to Nursing and Allied Health Literature; Current Contents: Clinical Medicine; Current Contents: Life Sciences; Excerpta Medica; Index Medicus; and Iowa Drug Information Service. The American Journal of Health-System Pharmacy is microfilmed by University Microfilms of Ann Arbor, Michigan.
Advertising is accepted in accordance with the ASHP Statement of Advertising Policy. Advertising will be accepted, subject to the editor’s approval, for prescription drug products as well as for other items used extensively in health systems. Inquiries should be sent to the editor.
TUTORIAL ON NAVIGATING THROUGH AJHP ONLINE
Click here to view a PowerPoint presentation on navigating through AJHP Online.
SECTIONS OF AJHP
The AJHP sections that include unsolicited papers are described here for readers, prospective authors, and reviewers. Not every section is represented in every issue.
Descriptions of submissions for regular AJHP columns (e.g., Letters, Management Consultation, Frontline Pharmacist) are printed each time the column appears.
Clinical Reviews: Literature reviews that focus primarily on a disease and its treatment, with emphasis on pharmacotherapy. Drug reviews are detailed, analytical reviews of the clinical use of new drugs. Evaluative literature reviews are preferred to reviews that are simply descriptive.
Therapy Updates: Concise analytical reviews of narrowly defined, important topics in pharmacotherapy; not intended to be comprehensive reviews of drugs or of diseases and their treatment. Articles that focus on new or emerging standards in drug therapy receive priority.
Clinical Frontiers: Articles that summarize important ongoing research on disease processes, drug mechanisms, or new technologies and project the likely implications for therapy.
Reports: Includes (1) reports of well-conducted original research, including clinical research on the effects of drugs in humans, surveys, drug stability studies, and evaluations of innovative pharmaceutical services and (2) descriptions (without substantive evaluations) of innovative pharmaceutical services.
Notes: Includes (1) practical innovations or solutions to everyday practice problems, (2) updates or elaborations on work previously published by the same authors, (3) confirmations of research findings previously published by others, and (4) short research reports, including practice surveys, of modest scope or interest. The text should be concise, and the number of references, tables, and figures should be limited.
Drug Experience: Straightforward reports of unusual drug experiences, with selected literature references.
Primers: Intended as introductions to various fields of knowledge that are of interest to pharmacists in health systems. Can be reviews of basic information in areas related to pharmacy (e.g., pharmaceutics or physiology) or those further from the mainstream of pharmacy (e.g., advances in nondrug health care technology).
Management Case Studies: Approaches to real-life management problems in health systems. Problem solving, not hypothesis testing, is emphasized.
Commentaries: Well-reasoned expressions of opinion on issues related to drug therapy, clinical research, the role of pharmacists in society, or health care (especially policy matters related to pharmaceutical services and to the therapeutic use of drugs).
Clinical Consultation: Brief advice, in question-and-answer format, on how to handle specific drug therapy problems. The answers are based largely on the author’s judgment and experience, although selected references should be cited, if available, to substantiate the advice.
Pharmacy Abroad: Brief, informal, and topical communications related to pharmacy in other countries. Contributions from pharmacists who live or have traveled abroad are welcome.
Reflections: Short contributions about the nontechnical sides of life. Satirical writings, literary pieces, histories and essays about family life, work, nature, art, literature, entertainment, travel, or modern society. Submissions are evaluated mainly for quality of the writing.
COLUMNS OF AJHPThe Alternative Therapies column features short reviews of herbals and other “nutraceuticals” for which there is some scientific evidence of effectiveness. The contributing editor for Alternative Therapies is Joseph Pepping, Pharm.D., Complementary Medicine Consultant, Kaiser Permanente, Honolulu, HI.
The Current Literature column features brief reviews of print and electronic publications (e.g., CD-ROMs and software) that are of interest to pharmacists. Reviews of fiction and nonfiction publications loosely related to health care are also included at the editors’ discretion.
The Frontline Pharmacist column gives staff pharmacists an opportunity to share their experiences and pertinent lessons related to day-to-day practice. Topics include workplace innovations, cooperating with peers, communicating with other professionals, dealing with management, handling technical issues related to pharmacy practice, and supervising technicians.
The Letters column is a forum for rapid exchange of ideas among readers of AJHP. Liberal criteria are applied in the review of submissions to encourage contributions to this column. The Letters column includes the following types of contributions: (1) comments, addenda, and minor updates on previously published work, (2) alerts on potential problems in practice, (3) observations or comments on trends in drug use, (4) opinions on apparent trends or controversies in drug therapy or clinical research, (5) opinions on public health issues of interest to pharmacists in health systems, (6) comments on ASHP activities, and (7) human interest items about life as a pharmacist. Reports of adverse drug reactions must present a reasonably clear description of causality. Short papers on practice innovations and other original work are included in the Notes section rather than in Letters. Letters commenting on an AJHP article must be received within three months of the article's publication.
The following conditions must be adhered to: (1) the body of the letter must be no longer than two typewritten pages, (2) the use of references and tables should be minimized, (3) the number of authors should be no more than three, (4) the authors’ names, affiliations, and mailing addresses must be typed at the end of the letter in the format used by AJHP, and (5) the entire letter (including references, tables, and authors’ names) must be typed double-spaced. After acceptance of a letter, the authors are required to sign an exclusive publication statement and a copyright transferal form. All letters are subject to revision by the editors.
The Management Consultation column gives readers an opportunity to obtain advice on common management problems from pharmacists practicing in health systems. AJHP readers are invited to submit questions for this column. Selected questions will be forwarded to one or two experts in the field, who will prepare brief responses for publication. Questions should be narrow in scope, such that they can be answered in approximately 500 words. Responses will be sent to the inquirer before publication. Readers are also invited to comment on the answers of consultants; such comments will be considered for the Letters column.
The Q & A column features ASHP staff responses to inquiries from pharmacists in health systems. Through this column, more practitioners can benefit from the answers prepared by the staff. The column may also include answers solicited from others, including government agencies such as OSHA, FDA, and DEA.
The New Practitioners Forum column features articles that address the special professional needs of pharmacists early in their careers as they transition from students to practitioners. Authors include new practitioners or others with expertise in a topic of interest to new practitioners.
The Informatics Interchange column gives readers an opportunity to share their experiences with information technology in pharmacy. Topics should focus on the use of information technology in the medication use process, informatics pearls, informatics education and research, and information technology management.
Readers who wish to suggest topics for columns or are interested in submitting manuscripts for columns should contact AJHP at 7272 Wisconsin Avenue, Bethesda, MD 20814 (301-664-8601, ajhp{at}ashp.org.
EDITORIAL STAFF
C. Richard Talley
EDITOR IN CHIEF
Maryam R. Mohassel, Pharm.D., BCPS
MANAGING EDITOR
MANUSCRIPT DEVELOPMENT
Guy R. Hasegawa, Pharm.D.
SENIOR EDITOR
Lori N. Justice, Pharm.D.
ASSOCIATE EDITOR
Sharon Kim Park, Pharm.D., BCPS
ASSISTANT EDITOR
REDACTION
Stacy Boyer, M.S.
ASSOCIATE EDITOR
Tia Morris
ASSISTANT EDITOR
Cheryl A. Thompson, M.A.
DIRECTOR, NEWS CENTER
Kate Traynor, M.S.
NEWS WRITER
Greg Lavine, B.S.
NEWS WRITER
Nasrine L. Sabi
ADVERTISING MANAGER
Deloris Drummings
ADMINISTRATIVE ASSISTANT
PRODUCTION CENTER
Johnna M. Hershey
DIRECTOR
Anita R. Lonesome
PRODUCTION MANAGER
Yvonne M. Yirka
SENIOR PRODUCTION ASSOCIATE
Michaelene W. Morgan
PRODUCTION ASSOCIATE
William P. Fogle
EDITORIAL RESOURCE MANAGER
Kristin Eckles
PROJECT EDITOR
David Wade
PUBLISHING DESIGN MANAGER
Carol A. Barrer
PRODUCTION PROJECT PLANNER
Hector L. Coronado, B.S.
CREATIVE DESIGNER
Larry Mann
CONTINUING-EDUCATION SPECIALIST
Editorial Office
7272 Wisconsin Avenue
Bethesda, MD
301-657-3000
fax: 301-664-8857
Email: ajhp{at}ashp.org
Web site: www.ashp.org
Statement of Ownership, Management and Circulation (Required by 39 U.S.C. 3685) 1. Title of publication, American Journal of Health-System Pharmacy. 2. Publication No. 1079-2082. 3. Date of filing, October 1, 2007. 4. Frequency of issue, Twice monthly. 5. No. issues published annually, 24. 6. Annual subscription price, $255.00. 7. Location of known office of publication, 7272 Wisconsin Avenue, Bethesda, Montgomery County, MD 20814-4836. 8. Location of the headquarters or general business offices of publishers, 7272 Wisconsin Avenue, Bethesda, MD 20814-4836. 9. Publisher, American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, MD 20814-4836. Editor, C. Richard Talley, 7272 Wisconsin Avenue, Bethesda, MD 20814-4836. 10. Owner, American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, MD 20814-4836. 11. Known bondholders, mortgagees, and other security holders owning 1% or more of total amount of bonds, mortgages, and other securities, None. 12. For completion by nonprofit organizations authorized to mail at special rates (Section 132.122, PSM). The purpose, function, and nonprofit status of this organization and the exempt status for federal income tax purposes have not changed during preceding 12 months. 13. Publication name, American Journal of Health-System Pharmacy. 14. Issue date for circulation data below, 9/15/2007. 15. Extent and nature of circulation, A. Total no. copies printed, 36,648/34,727*; B. Paid circulation, 1. Sales through dealers and carriers, street vendors, and counter sales, 425/0. 2. Paid or requested mail subscriptions, 28,363/27,250; C. Total paid or requested circulation, 28,788/27,250; D. Free distribution by mail, 6,981/6,571; E. Free distribution outside the mail, 0/0. F. Total free distribution, 6,981/6,571. G. Total distribution, 35,769/33,821; H. Copies not distributed, 1. Office use, left over, spoiled, 1,304/908. 2. Returns from news agents, 0, 0; I. Total, 36,648/34,729. Percent paid circulation, 80.5/80.6. I certify that the statements made by me are correct and complete, signed C. Richard Talley.
*First figure, average no. copies of each issue during preceding 12 months; second figure, actual no. copies of single issue published nearest to filing date.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |